Search

Your search keyword '"Jelinek, Tomas"' showing total 859 results

Search Constraints

Start Over You searched for: Author "Jelinek, Tomas" Remove constraint Author: "Jelinek, Tomas"
859 results on '"Jelinek, Tomas"'

Search Results

1. Dense Matchers for Dense Tracking

2. Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies

4. Morphological Tagging and Lemmatization of Spoken Corpora of Czech

5. Autorinnen und Autoren

13. Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

14. SYN2020: A New Corpus of Czech with an Innovated Annotation

15. FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

18. Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia

19. Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions.

20. Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti‐CD38 therapy.

21. Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis.

22. Using a Database of Multiword Expressions in Dependency Parsing

23. Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries

24. Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice

25. Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti‐CD38 therapy

26. P-159 Lenalidomide maintenance in R2-ISS stratified multiple myeloma patients - real world evidence

27. P-075 Real-world evidence on prognostic value of minimal residual disease in multiple myeloma: Czech experience

28. Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

29. Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination

32. Eye of a Needle in a Haystack : Multiword Expressions in Czech: Typology and Lexicon

33. Errors in Inflection in Czech as a Second Language and Their Automatic Classification

38. Supplementary Figure 3 from The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma

39. Supplementary Figure 4 from The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma

40. Supplementary Figure 5 from The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma

41. Supplementary Figure 1 from The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma

42. Supplementary Figure 2 from The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma

43. Combining Dependency Parsers Using Error Rates

45. Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial

47. Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech Registry Data

48. Chikungunya: risks for travellers

Catalog

Books, media, physical & digital resources